TATA HEALTH (01255) Offloads Loss-Making Unit for HK$1, Eyes HK$4.10 Million Gain

Bulletin Express
03/13

TATA Health International Holdings Limited announced that on 13 March 2026 its wholly-owned subsidiary, S. Culture Holdings (BVI) Limited, disposed of the entire issued share capital of Kong Tai Sundry Goods (BVI) Company Limited (the “Target Company”) to Wealthy Steps Company Limited for a cash consideration of HK$1.00. Completion occurred on the same day, and the Target Company and its subsidiaries (“Target Group”) have ceased to be consolidated into TATA HEALTH’s financial statements.

The Target Group held net liabilities of approximately HK$4.10 million and unaudited total assets of HK$22.30 million as at 31 December 2025. For 2025, the Target Group generated revenue of HK$8.78 million and recorded a net loss after tax of HK$15.88 million; the prior year posted a HK$31.20 million net loss on revenue of HK$9.07 million.

Management cited the Target Group’s persistent losses, indebtedness and lack of future business prospects as key reasons for the divestment, noting that ongoing financial support was no longer justifiable. The disposal is expected to deliver an accounting gain of roughly HK$4.10 million, calculated as the elimination of the Target Group’s net liabilities less transaction costs, thereby improving the Group’s liquidity and allowing resources to be redirected to its core footwear operations.

Under Hong Kong Listing Rules, the transaction meets the thresholds for a disclosable transaction (percentage ratios above 5% but below 25%) and therefore requires announcement but not shareholder approval or circular issuance.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10